NDLI: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

Content Provider	PubMed Central
Author	Zhang, Hao Liang, Xi Duan, Chao Liu, Caigang Zhao, Zuowei
Editor	Glynn, Sharon A.
Copyright Year	2014
Abstract	Galectin-3 has a relatively high level of expression in triple-negative breast cancers and is a potential marker for this disease. However, the clinical and prognostic implications of galectin-3 expression in breast cancer remain unclear. We examined mastectomy specimens from 1086 breast cancer cases and matching, adjacent non-cancerous tissues using immunohistochemistry. Overall, triple-negative breast cancers expressed galectin-3 more strongly than did other breast cancers types (63.59% vs 21.36%, P = 0.001). Galectin-3 expression was not found to be an independent prognostic factor for breast cancer by Cox regression analysis, but was associated with chemotherapeutic resistance. Apoptosis was only weakly induced by arsenic trioxide (ATO) treatment in galectin-3-positive breast cancer cells (MDA-MB-231 and MCF-7), although ATO treatment up-regulated galectin-3 expression. Knockdown of galectin-3 in MDA-MB-231 cells sensitized them to killing by ATO. These findings support a possible role for galectin-3 as a marker for triple-negative breast cancer progression and as a therapeutic target in combination with ATO treatment, although the mechanisms that underlie this synergy require further investigation.
Related Links	http://dx.doi.org/10.1371/journal.pone.0103482
Starting Page	103482
File Format	PDF
ISSN	19326203
e-ISSN	19326203
Journal	PLoS ONE
Issue Number	9
Volume Number	9
Language	English
Publisher	Public Library of Science
Publisher Date	2014-09-01
Access Restriction	Open
Rights Holder	Public Library of Science
Subject Keyword	Biochemistry, Genetics and Molecular Biology(all) Agricultural and Biological Sciences(all) Medicine(all) Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Multidisciplinary

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer

Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer

Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer

MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival

Meta-Analysis Identifies NF-κB as a Therapeutic Target in Renal Cancer

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

Similar Documents

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer

Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer

Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer

MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival

Meta-Analysis Identifies NF-κB as a Therapeutic Target in Renal Cancer

MET and PI3K/mTOR as a Potential Combinatorial Therapeutic Target in Malignant Pleural Mesothelioma

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer